Bookmark and Share
opioid receptor, kappa 1 [Homo sapiens] [gi:119607129] - Target BioActivity Data
Filters: All Data » Active      
Filter selected
BioActivity Outcomes:
Active(128)
 
 
BioAssay Types:
Screening(72)
 
 
Confirmatory(34)
 
 
BioActivity Types:
IC50(34)
 
 
Substance Types:
Chemical(128)
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 5    Data Row: 128   Total Pages: 3   Display: Page     
Sort: [Click the result table header to sort]
#StructureSubstanceCompoundActivityBioAssayLinks
OutcomeTypeValue [μM]
1
[SID144087319]
[CID60156214]
IC50 0.00916Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay, Set 2. [AID652084, Type: confirmatory]
View
2
[SID144087319]
[CID60156214]
IC50 0.0164Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay [AID652032, Type: confirmatory]
View
3
[SID144087324]
[CID60156231]
IC50 0.075Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay [AID652032, Type: confirmatory]
View
4
[SID144087321]
[CID60156232]
IC50 0.079Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay [AID652032, Type: confirmatory]
View
5
[SID144087313]
[CID60156237]
IC50 0.11Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay [AID652032, Type: confirmatory]
View
6
[SID144087314]
[CID60156217]
IC50 0.12Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay [AID652032, Type: confirmatory]
View
7
[SID144087303]
[CID60156211]
IC50 0.133Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay [AID652032, Type: confirmatory]
View
8
[SID144087323]
[CID60156212]
IC50 0.159Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay [AID652032, Type: confirmatory]
View
9
[SID144087309]
[CID60156221]
IC50 0.185Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay [AID652032, Type: confirmatory]
View
10
[SID144087298]
[CID60156210]
IC50 0.231Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay [AID652032, Type: confirmatory]
View
11
[SID144087315]
[CID60156235]
IC50 0.267Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay [AID652032, Type: confirmatory]
View
12
[SID144087322]
[CID60156234]
IC50 0.398Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay [AID652032, Type: confirmatory]
View
13
[SID160844010]
[CID2796048]
IC50 0.41Late-stage fluorescence-based cell-based dose response assay for antagonists of kappa opioid receptor 1 (OPRK1) [AID652077, Type: confirmatory]
View
14
[SID144087310]
[CID60156240]
IC50 0.536Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay [AID652032, Type: confirmatory]
View
15
[SID144087304]
[CID60156205]
IC50 0.579Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay [AID652032, Type: confirmatory]
View
16
[SID144087308]
[CID60156238]
IC50 0.621Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay [AID652032, Type: confirmatory]
View
17
[SID144087326]
[CID60156213]
IC50 0.628Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay [AID652032, Type: confirmatory]
View
18
[SID144087306]
[CID60156206]
IC50 0.652Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay [AID652032, Type: confirmatory]
View
19
[SID160844001]
[CID2809477]
IC50 1.05Late-stage fluorescence-based cell-based dose response assay for antagonists of kappa opioid receptor 1 (OPRK1) [AID652077, Type: confirmatory]
View
20
[SID160844008]
[CID2741001]
IC50 1.58Late-stage fluorescence-based cell-based dose response assay for antagonists of kappa opioid receptor 1 (OPRK1) [AID652077, Type: confirmatory]
View
21
[SID160844000]
[CID2812682]
IC50 1.82Late-stage fluorescence-based cell-based dose response assay for antagonists of kappa opioid receptor 1 (OPRK1) [AID652077, Type: confirmatory]
View
22
[SID160844007]
[CID2797279]
IC50 2.2Late-stage fluorescence-based cell-based dose response assay for antagonists of kappa opioid receptor 1 (OPRK1) [AID652077, Type: confirmatory]
View
23
[SID144087329]
[CID60156209]
IC50 2.2Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay [AID652032, Type: confirmatory]
View
24
[SID144087327]
[CID60156236]
IC50 2.6Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay [AID652032, Type: confirmatory]
View
25
[SID144087312]
[CID60156243]
IC50 2.7Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay [AID652032, Type: confirmatory]
View
26
[SID144087318]
[CID60156220]
IC50 3.5Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay [AID652032, Type: confirmatory]
View
27
[SID160844004]
[CID2812405]
IC50 4.66Late-stage fluorescence-based cell-based dose response assay for antagonists of kappa opioid receptor 1 (OPRK1) [AID652077, Type: confirmatory]
View
28
[SID144087320]
[CID60156224]
IC50 5.2Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay [AID652032, Type: confirmatory]
View
29
[SID144087330]
[CID60156208]
IC50 5.9Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay [AID652032, Type: confirmatory]
View
30
[SID144087316]
[CID60156230]
IC50 6.2Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay [AID652032, Type: confirmatory]
View
31
[SID144087325]
[CID60156227]
IC50 6.6Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay [AID652032, Type: confirmatory]
View
32
[SID144087311]
[CID60156219]
IC50 6.8Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay [AID652032, Type: confirmatory]
View
33
[SID160844006]
[CID2796792]
IC50 6.85Late-stage fluorescence-based cell-based dose response assay for antagonists of kappa opioid receptor 1 (OPRK1) [AID652077, Type: confirmatory]
View
34
[SID144087302]
[CID60156204]
IC50 9.2Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay [AID652032, Type: confirmatory]
View
35
[SID26528077]
[CID916059]
Maybridge screen to identify antagonists of kappa opioid receptor 1 (OPRK1): fluorescence-based cell-based assay [AID652031, Type: screening]
View
36
[SID26528267]
[CID2817759]
Maybridge screen to identify antagonists of kappa opioid receptor 1 (OPRK1): fluorescence-based cell-based assay [AID652031, Type: screening]
View
37
[SID26528314]
[CID9566157]
Maybridge screen to identify antagonists of kappa opioid receptor 1 (OPRK1): fluorescence-based cell-based assay [AID652031, Type: screening]
View
38
[SID26528314]
[CID9566157]
Fluorescence-based cell-based confirmation assay for antagonists of kappa opioid receptor 1 (OPRK1) [AID652082, Type: other]
View
39
[SID26528584]
[CID9580508]
Maybridge screen to identify antagonists of kappa opioid receptor 1 (OPRK1): fluorescence-based cell-based assay [AID652031, Type: screening]
View
40
[SID26528584]
[CID9580508]
Fluorescence-based cell-based confirmation assay for antagonists of kappa opioid receptor 1 (OPRK1) [AID652082, Type: other]
View
41
[SID26528633]
[CID2726662]
Maybridge screen to identify antagonists of kappa opioid receptor 1 (OPRK1): fluorescence-based cell-based assay [AID652031, Type: screening]
View
42
[SID26528710]
[CID3383009]
Maybridge screen to identify antagonists of kappa opioid receptor 1 (OPRK1): fluorescence-based cell-based assay [AID652031, Type: screening]
View
43
[SID26528725]
[CID2801995]
Maybridge screen to identify antagonists of kappa opioid receptor 1 (OPRK1): fluorescence-based cell-based assay [AID652031, Type: screening]
View
44
[SID26528774]
[CID2821061]
Maybridge screen to identify antagonists of kappa opioid receptor 1 (OPRK1): fluorescence-based cell-based assay [AID652031, Type: screening]
View
45
[SID26529317]
[CID2811078]
Maybridge screen to identify antagonists of kappa opioid receptor 1 (OPRK1): fluorescence-based cell-based assay [AID652031, Type: screening]
View
46
[SID26529317]
[CID2811078]
Fluorescence-based cell-based confirmation assay for antagonists of kappa opioid receptor 1 (OPRK1) [AID652082, Type: other]
View
47
[SID26529976]
[CID2817538]
Maybridge screen to identify antagonists of kappa opioid receptor 1 (OPRK1): fluorescence-based cell-based assay [AID652031, Type: screening]
View
48
[SID26529976]
[CID2817538]
Fluorescence-based cell-based confirmation assay for antagonists of kappa opioid receptor 1 (OPRK1) [AID652082, Type: other]
View
49
[SID26530313]
[CID2801235]
Maybridge screen to identify antagonists of kappa opioid receptor 1 (OPRK1): fluorescence-based cell-based assay [AID652031, Type: screening]
View
50
[SID26530487]
[CID2747705]
Maybridge screen to identify antagonists of kappa opioid receptor 1 (OPRK1): fluorescence-based cell-based assay [AID652031, Type: screening]
View